IDH1 and glioma: We subsequently evaluated modifications induced by the PSFd application on two clinical classification tasks previously shown to be relevant for the initial diagnosis of gliomas with amino-acid PET imaging; namely the prediction of the IDH mutation and the 1p/19q codeletion [9], which are two key-molecular characteristics defined in the current WHO 2021 glioma classification [11].